Fortress Biotech
FBIO
#9379
Rank
โ‚ฌ75.44 M
Marketcap
2,43ย โ‚ฌ
Share price
2.91%
Change (1 day)
24.90%
Change (1 year)

Revenue for Fortress Biotech (FBIO)

Revenue in 2025 (TTM): โ‚ฌ53.73 Million

According to Fortress Biotech 's latest financial reports the company's current revenue (TTM ) is โ‚ฌ50.93 Million. In 2024 the company made a revenue of โ‚ฌ55.42 Million a decrease over the revenue in the year 2023 that were of โ‚ฌ76.45 Million. The revenue is the total amount of income that a company generates by the sale of goods or services. Unlike with the earnings no expenses are subtracted.

Revenue history for Fortress Biotech from 2011 to 2025

Annual revenue

Year Revenue Change
2025 (TTM) โ‚ฌ53.73 M-3.05%
2024 โ‚ฌ55.42 M-27.5%
2023 โ‚ฌ76.45 M8.27%
2022 โ‚ฌ70.61 M16.25%
2021 โ‚ฌ60.74 M63.85%
2020 โ‚ฌ37.07 M13.38%
2019 โ‚ฌ32.69 M-127.07%
2018 -โ‚ฌ0.13 Billion-177.26%
2017 โ‚ฌ0.15 B897.85%
2016 โ‚ฌ15.66 M1885.05%
2015 โ‚ฌ0.78 M
2014 N/A
2013 N/A
2012 N/A
2011 N/A

Revenue for similar companies or competitors

Company Revenue Revenue differencediff. Country
Advaxis
ADXS
โ‚ฌ0.09 M-99.81%๐Ÿ‡บ๐Ÿ‡ธ USA
Veracyte
VCYT
โ‚ฌ0.42 B 734.96%๐Ÿ‡บ๐Ÿ‡ธ USA
Dicerna Pharmaceuticals
DRNA
โ‚ฌ0.16 B 225.21%๐Ÿ‡บ๐Ÿ‡ธ USA
Dynavax Technologies
DVAX
โ‚ฌ0.28 B 457.35%๐Ÿ‡บ๐Ÿ‡ธ USA